BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8613919)

  • 1. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
    Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
    Katz JL; Izenwasser S; Kline RH; Allen AC; Newman AH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):302-15. PubMed ID: 9862785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
    Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey.
    Howell LL; Czoty PW; Kuhar MJ; Carrol FI
    J Pharmacol Exp Ther; 2000 Feb; 292(2):521-9. PubMed ID: 10640288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of rimcazole analogues alone and in combination with cocaine.
    Katz JL; Libby TA; Kopajtic T; Husbands SM; Newman AH
    Eur J Pharmacol; 2003 May; 468(2):109-19. PubMed ID: 12742518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interaction of GBR 12909, a dopamine uptake inhibitor, with cocaine and methamphetamine in rats discriminating cocaine.
    Holtzman SG
    Psychopharmacology (Berl); 2001 May; 155(2):180-6. PubMed ID: 11401007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction.
    Rothman RB; Baumann MH; Prisinzano TE; Newman AH
    Biochem Pharmacol; 2008 Jan; 75(1):2-16. PubMed ID: 17897630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence.
    Tella SR
    Pharmacol Biochem Behav; 1996 Jun; 54(2):343-54. PubMed ID: 8743594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel benztropine [3a-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporter.
    Newman AH; Agoston GE
    Curr Med Chem; 1998 Aug; 5(4):305-19. PubMed ID: 9668197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL; Kopajtic TA; Agoston GE; Newman AH
    J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats.
    Zanettini C; Wilkinson DS; Katz JL
    Psychopharmacology (Berl); 2018 Jan; 235(1):47-58. PubMed ID: 28932889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA; Newman AH; Eddington ND
    J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats.
    Tanda G; Ebbs AL; Kopajtic TA; Elias LM; Campbell BL; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2007 Apr; 321(1):334-44. PubMed ID: 17255465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey.
    Howell LL; Byrd LD
    J Pharmacol Exp Ther; 1991 Jul; 258(1):178-85. PubMed ID: 1677037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.
    Slezak JM; Desai RI; Katz JL
    Behav Pharmacol; 2017 Feb; 28(1):74-82. PubMed ID: 27926573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.